Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Research & Development (2016 - 2025)

Historic Research & Development for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $3.0 million.

  • Lemaitre Vascular's Research & Development fell 1876.37% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year decrease of 1317.83%. This contributed to the annual value of $15.6 million for FY2024, which is 775.67% down from last year.
  • As of Q3 2025, Lemaitre Vascular's Research & Development stood at $3.0 million, which was down 1876.37% from $3.5 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Research & Development high stood at $4.5 million for Q2 2023, and its period low was $2.7 million during Q2 2021.
  • Over the past 5 years, Lemaitre Vascular's median Research & Development value was $3.6 million (recorded in 2022), while the average stood at $3.6 million.
  • In the last 5 years, Lemaitre Vascular's Research & Development surged by 3574.83% in 2021 and then tumbled by 1876.37% in 2025.
  • Lemaitre Vascular's Research & Development (Quarter) stood at $3.5 million in 2021, then grew by 2.81% to $3.6 million in 2022, then grew by 22.43% to $4.4 million in 2023, then fell by 16.85% to $3.6 million in 2024, then dropped by 17.91% to $3.0 million in 2025.
  • Its Research & Development was $3.0 million in Q3 2025, compared to $3.5 million in Q2 2025 and $4.1 million in Q1 2025.